Latest Articles

  • Antireflux surgery in the proton pump inhibitor era
    Antireflux surgery in the proton pump inhibitor era
    William J. Bulsiewicz, MD, MSc and Ryan D. Madanick, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 273-281; DOI: https://doi.org/10.3949/ccjm.79a.11097

    Although drug therapy with a proton pump inhibitor is the first-line treatment for gastro-esophageal reflux disease, surgery still has several specific indications.

  • In Reply: Parkinson disease (January 2012)
    Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 243-248; DOI: https://doi.org/10.3949/ccjm.79c:04007

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Building an innovative model for personalized healthcare
    Kathryn Teng, MD, Charis Eng, MD, PhD, Caryl A. Hess, PhD, MBA, Meredith A. Holt, MBA, Rocio T. Moran, MD, Richard R. Sharp, PhD and Elias I. Traboulsi, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4 suppl 1) S1-S9; DOI: https://doi.org/10.3949/ccjm.79.s1.01
  • Update on contraceptive options: A case-based discussion
    Kristi Tough, MD and Holly L. Thacker, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 207-212; DOI: https://doi.org/10.3949/ccjm.79a.11088

    Contraceptive counseling is both an art and a science. Here, the authors present several common scenarios.

  • Protease inhibitors: Silver bullets for chronic hepatitis C infection?
    Protease inhibitors: Silver bullets for chronic hepatitis C infection?
    Naim Alkhouri, MD and Nizar N. Zein, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 213-222; DOI: https://doi.org/10.3949/ccjm.79a.11082

    These new drugs are a major step forward, and multidrug regimens that include them are the new standard of care.

  • Correction
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 222;
  • Reviewers 2011
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 192;
  • Cervical cancer screening (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 164; DOI: https://doi.org/10.3949/ccjm.79c:03001

    Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).

  • Exploring the human genome, and relearning genetics by necessity
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 162; DOI: https://doi.org/10.3949/ccjm.79b.12003

    The field of medical genetics continues to advance far beyond what many of us were exposed to in medical school.

  • In reply: Dabigatran (October 2011)
    Siddharth A. Wartak, MD and John R. Bartholomew, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 168-169; DOI: https://doi.org/10.3949/ccjm.79c:03005

Pages